HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phil-Ok Koh Selected Research

Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)

5/2022Retinoic acid regulates the ubiquitin-proteasome system in a middle cerebral artery occlusion animal model.
2/2021Quercetin attenuates the reduction of parvalbumin in middle cerebral artery occlusion animal model.
1/2020Quercetin Attenuates Decrease of Thioredoxin Expression Following Focal Cerebral Ischemia and Glutamate-induced Neuronal Cell Damage.
7/2019Quercetin alleviates the injury-induced decrease of protein phosphatase 2A subunit B in cerebral ischemic animal model and glutamate-exposed HT22 cells.
1/2019Resveratrol modulates the Akt/GSK-3β signaling pathway in a middle cerebral artery occlusion animal model.
1/2019Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways.
12/2018Hyperglycemia aggravates decrease in alpha-synuclein expression in a middle cerebral artery occlusion model.
8/2018Identification of Proteins Differentially Expressed by Quercetin Treatment in a Middle Cerebral Artery Occlusion Model: A Proteomics Approach.
4/2018Quercetin attenuates neuronal cells damage in a middle cerebral artery occlusion animal model.
1/2018Identification of Proteins Differentially Expressed in the Striatum by Melatonin in a Middle Cerebral Artery Occlusion Rat Model-a Proteomic and in silico Approach.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Phil-Ok Koh Research Topics

Disease

57Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2022 - 03/2006
46Brain Ischemia (Cerebral Ischemia)
09/2022 - 01/2009
40Brain Injuries (Brain Injury)
01/2020 - 03/2006
21Infarction (Infarctions)
01/2021 - 03/2006
9Ischemia
01/2021 - 11/2010
8Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 01/2007
5Stroke (Strokes)
01/2019 - 10/2014
5Hyperglycemia
12/2018 - 01/2016
4Ischemic Stroke
09/2022 - 01/2018
4Brain Edema (Cerebral Edema)
01/2021 - 04/2018
4Inflammation (Inflammations)
01/2020 - 05/2012
3Neuroinflammatory Diseases
01/2022 - 10/2019
3Body Weight (Weight, Body)
08/2017 - 09/2007
1Dermatitis
10/2021
1Atopic Dermatitis (Atopic Eczema)
10/2021
1Acne Vulgaris
03/2020
1Edema (Dropsy)
03/2020
1Neoplasms (Cancer)
07/2019
1Spermatic Cord Torsion (Testicular Torsion)
03/2014
1Reperfusion Injury
11/2010

Drug/Important Bio-Agent (IBA)

34Neuroprotective AgentsIBA
09/2022 - 07/2008
27Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2006
19Glutamic Acid (Glutamate)FDA Link
02/2021 - 11/2011
14AntioxidantsIBA
02/2021 - 01/2012
14MelatoninIBA
01/2019 - 01/2008
11ferulic acid (sodium ferulate)IBA
02/2015 - 01/2012
9Streptozocin (Streptozotocin)FDA Link
12/2018 - 09/2007
8QuercetinIBA
03/2022 - 12/2017
8ParvalbuminsIBA
02/2021 - 03/2012
7HippocalcinIBA
01/2020 - 09/2012
7Estradiol (Delestrogen)FDA LinkGeneric
03/2015 - 03/2006
7Ginkgo biloba extract (Rokan)IBA
09/2012 - 01/2009
6CalciumIBA
01/2022 - 11/2012
5Niacinamide (Nicotinamide)FDA LinkGeneric
06/2013 - 07/2011
4Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
09/2015 - 03/2011
4Phosphotransferases (Kinase)IBA
10/2013 - 05/2008
3Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2022 - 01/2021
3NF-kappa B (NF-kB)IBA
01/2022 - 10/2019
3triphenyltetrazoliumIBA
01/2019 - 01/2012
3Phosphopyruvate Hydratase (Enolase)IBA
12/2017 - 03/2014
3CurcuminIBA
03/2016 - 09/2015
2Chlorogenic AcidIBA
01/2022 - 01/2021
2ThioredoxinsIBA
01/2020 - 04/2014
2baicalinIBA
01/2020 - 10/2019
2FlavonoidsIBA
07/2019 - 08/2018
2Semaphorin-3AIBA
01/2019 - 06/2013
2ResveratrolIBA
01/2019 - 10/2014
2SynucleinsIBA
12/2018 - 09/2017
2Dynamins (Dynamin)IBA
09/2017 - 12/2016
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
02/2015 - 01/2012
2Protein Isoforms (Isoforms)IBA
12/2012 - 07/2008
2Nitric Oxide Synthase (NO Synthase)IBA
12/2012 - 07/2008
1Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA
05/2022
1UbiquitinIBA
05/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
05/2022
1PolyphenolsIBA
03/2022
1Glial Fibrillary Acidic ProteinIBA
01/2022
1Dinitrochlorobenzene (DNCB)IBA
10/2021
1CaspasesIBA
01/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2020
1Caspase 3 (Caspase-3)IBA
05/2020
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
05/2020
1Pharmaceutical PreparationsIBA
03/2020
1ChemokinesIBA
03/2020
1CosmeticsIBA
03/2020
1LipopolysaccharidesIBA
10/2019
1propionic acid (potassium propionate)IBA
01/2019
1AMPA Receptors (AMPA Receptor)IBA
01/2019
1N-Methylaspartate (NMDA)IBA
01/2019
1Glycogen Synthase (Synthase I)IBA
01/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2019
1alpha-SynucleinIBA
12/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1Blood Glucose (Blood Sugar)IBA
08/2017
114-3-3 Proteins (14-3-3 Protein)IBA
01/2016
1Mitogen-Activated Protein KinasesIBA
09/2015
1PhytochemicalsIBA
04/2014
1Protective AgentsIBA
03/2014
1CalbindinsIBA
09/2013
1EnzymesIBA
11/2012
1Serine (L-Serine)FDA Link
03/2012
1PhosphoproteinsIBA
11/2011
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2008
1Estrogens (Estrogen)FDA Link
03/2006

Therapy/Procedure

2Intravenous Injections
09/2007 - 09/2007
1Intraperitoneal Injections
12/2017
1Ovariectomy (Oophorectomy)
10/2014
1Transplantation
01/2007